The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel

BACKGROUND: Different platelet function tests can be used to evaluate the degree of achieved platelet inhibition in patients treated with clopidogrel. The presence of CYP 2C19*2 polymorphism can reduce the formation of the active metabolite of clopidogrel, resulting in less platelet inhibition. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettersen, Alf-Aage R, Arnesen, Harald, Opstad, Trine B, Seljeflot, Ingebjorg
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071307/
https://www.ncbi.nlm.nih.gov/pubmed/21426546
http://dx.doi.org/10.1186/1477-9560-9-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071307/
https://www.ncbi.nlm.nih.gov/pubmed/21426546
http://dx.doi.org/10.1186/1477-9560-9-4

Ejemplares similares